Form 4: Hookipa Pharma Director Acquires Stock Options

Director Timothy P. Reilly acquired stock options for 49,000 shares of Hookipa Pharma Inc. on June 17, 2024.

Summary

• Timothy P. Reilly, a director of Hookipa Pharma Inc., filed a Form 4 on June 18, 2024.
• The filing reports a transaction that occurred on June 17, 2024, where Reilly acquired stock options for 49,000 shares of Hookipa Pharma Inc.
• The exercise price of the stock options is $0.71.
• The options vest on the earlier of June 17, 2025, or the date of the Issuer's next annual meeting of its stockholders and expire on June 17, 2034.
• Following the transaction, Reilly directly owns derivative securities for 49,000 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a director can be interpreted as a sign of confidence in the company's future, but it's a routine transaction.

Positives

• A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, such as directors and officers, trade in their company's securities. These filings provide transparency to the market regarding insider activity.

Stakeholder Impact

• The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.

Key Dates